Heidi A. Schwanz, PhD
Postdoctoral Fellow
Boston University School of Medicine
Dept of Physiology & Biophysics




Postdoctoral Fellow
Boston University School of Medicine
Department of Cardiovascular Institute (Whitaker)


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Malik M, Mustaev A, Schwanz HA, Luan G, Shah N, Oppegard LM, de Souza EC, Hiasa H, Zhao X, Kerns RJ, Drlica K. Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones. Nucleic Acids Res. 2016 Apr 20; 44(7):3304-16. PMID: 26984528; PMCID: PMC4838383; DOI: 10.1093/nar/gkw161;.
  2. Oppegard LM, Schwanz HA, Towle TR, Kerns RJ, Hiasa H. Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg(2+) to the second metal binding site. Biochim Biophys Acta. 2016 Mar; 1860(3):569-75. PMID: 26723176; PMCID: PMC4720527; DOI: 10.1016/j.bbagen.2015.12.019;.
  3. Aldred KJ, Schwanz HA, Li G, Williamson BH, McPherson SA, Turnbough CL, Kerns RJ, Osheroff N. Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions. Biochemistry. 2015 Feb 10; 54(5):1278-86. PMID: 25586498; PMCID: PMC4427193; DOI: 10.1021/bi501073v;.
  4. Wong S, Kirkland JL, Schwanz HA, Simmons AL, Hamilton JA, Corkey BE, Guo W. Effects of thiol antioxidant ß-mercaptoethanol on diet-induced obese mice. Life Sci. 2014 Jun 27; 107(1-2):32-41.View Related Profiles. PMID: 24802126; DOI: 10.1016/j.lfs.2014.04.031;.
  5. Aldred KJ, Schwanz HA, Li G, McPherson SA, Turnbough CL, Kerns RJ, Osheroff N. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions. ACS Chem Biol. 2013 Dec 20; 8(12):2660-8. PMID: 24047414; PMCID: PMC3870039; DOI: 10.1021/cb400592n;.
  6. Malik M, Marks KR, Schwanz HA, German N, Drlica K, Kerns RJ. Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality. Antimicrob Agents Chemother. 2010 Dec; 54(12):5214-21. PMID: 20855738; PMCID: PMC2981251.
  7. Oppegard LM, Streck KR, Rosen JD, Schwanz HA, Drlica K, Kerns RJ, Hiasa H. Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones. Antimicrob Agents Chemother. 2010 Jul; 54(7):3011-4. PMID: 20404126; PMCID: PMC2897325.
  8. Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, Dawson DB, Harris PC, Milliner DS. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol. 2007 Jun; 18(6):1905-14. PMID: 17460142.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 8 publications over 6 distinct years, with a maximum of 2 publications in 2010 and 2015

YearPublications
20071
20102
20131
20141
20152
20161
Contact for Mentoring:


700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map


Schwanz's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department